Shannon Campbell serves as Executive at Black Diamond Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Shannon Campbell has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 20, 2024 involved receiving (via award) 2,354 shares valued at $11.3K.
Shannon Campbell currently holds 4,365 shares of Black Diamond Therapeutics, Inc. (BDTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Shannon Campbell has been a net neutral trader of BDTX stock. They have purchased $0 and sold $0 worth of shares.
Shannon Campbell's most recent insider trade was on Sep 20, 2024, when they sold 2,354 shares at $4.78 per share.
Get notified when new Form 4 filings are submitted
| $4.98 |
| Discretionary |